Based on the analysis of The Cancer Genome Atlas (TCGA), v10 is one of the most abundant variable exons in CD44, and its expression has been shown to be most highly correlated among the breast cancer specimens [48]. This evidence concerns the gene CD44 and breast carcinoma.